يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Rita Agostino"', وقت الاستعلام: 0.87s تنقيح النتائج
  1. 1
    Could PD-1/PDL1 immune checkpoints be linked to HLA signature?

    المؤلفون: Valerio Nardone, Rita Emilena Saladino, Pierosandro Tagliaferri, Rita Agostino, Luigi Pirtoli, Rocco Giannicola, Ciro Botta, Michele Caraglia, Pierpaolo Correale

    المساهمون: Correale P., Saladino R.E., Nardone V., Giannicola R., Agostino R., Pirtoli L., Caraglia M., Botta C., Tagliaferri P., Correale, P., Saladino, R. E., Nardone, V., Giannicola, R., Agostino, R., Pirtoli, L., Caraglia, M., Botta, C., Tagliaferri, P.

    المصدر: Immunotherapy. 11:1523-1526

    مصطلحات موضوعية: Drug-Related Side Effects and Adverse Reactions, Programmed Cell Death 1 Receptor, Immunology, Antibodies, Monoclon al, Human leukocyte antigen, B7-H1 Antigen, Immune system, HLA Antigens, irAE, Neoplasms, Humans, Immunology and Allergy, Medicine, PD-1/PDL-1-blockade, business.industry, Antibodies, Monoclonal, Biomarker, Signature (logic), Haplotypes, Oncology, outcome, Immunotherapy, HLA allele, Drug-Related Side Effects and Adverse Reaction, business, Biomarkers

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c70213e3b3eb8b72144bf5a6bb289900Test
    https://doi.org/10.2217/imt-2019-0160Test


    أضف إلى المفضلة
  2. 2
    Myositis/myasthenia after pembrolizumab in a bladder cancer patient with an autoimmunity-associated HLA: Immune–biological evaluation and case report

    المؤلفون: Roberto Maisano, Giovanna Orizzonte, Giorgio Restifo, Pierpaolo Correale, Michele Caraglia, Vincenzo Dattola, Cirino Botta, Rita Agostino, Rita Emilena Saladino, Domenico Mazzacuva, Rocco Giannicola, Antonia Consuelo Falzea, Natale Daniele Calandruccio, Antonino Mafodda, Umberto Aguglia, Giovanna Bianco, Eleonora Iuliano, Vittoria Cianci

    المساهمون: Botta, C., Agostino, R. M., Dattola, V., Cianci, V., Calandruccio, N. D., Bianco, G., Mafodda, A., Maisano, R., Iuliano, E., Orizzonte, G., Mazzacuva, D., Falzea, A. C., Saladino, R. E., Giannicola, R., Restifo, G., Aguglia, U., Caraglia, M., Correale, P., Botta C., Agostino R.M., Dattola V., Cianci V., Calandruccio N.D., Bianco G., Mafodda A., Maisano R., Iuliano E., Orizzonte G., Mazzacuva D., Falzea A.C., Saladino R.E., Giannicola R., Restifo G., Aguglia U., Caraglia M., Correale P.

    المصدر: International Journal of Molecular Sciences, Vol 22, Iss 6246, p 6246 (2021)
    International Journal of Molecular Sciences

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Case Report, Autoimmunity, Pembrolizumab, PD1-checkpoint inhibitors, medicine.disease_cause, 0302 clinical medicine, Antineoplastic Agents, Immunological, Biology (General), HLA Antigen, Myositi, PD1-checkpoint inhibitor, Spectroscopy, Myositis, General Medicine, Computer Science Applications, Myasthenia Gravi, Chemistry, Pyridostigmine, urothelial cancer, 030220 oncology & carcinogenesis, Urinary Bladder Neoplasm, Class-I/II HLA, Myasthenia, medicine.drug, Human, medicine.medical_specialty, QH301-705.5, Prognosi, Human leukocyte antigen, Antibodies, Monoclonal, Humanized, Catalysis, Inorganic Chemistry, 03 medical and health sciences, Internal medicine, medicine, Physical and Theoretical Chemistry, Adverse effect, Molecular Biology, QD1-999, Aged, business.industry, Organic Chemistry, Cancer, medicine.disease, Discontinuation, 030104 developmental biology, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5f1730fa5ddbbe610ba6d945569661Test
    http://hdl.handle.net/11591/462420Test


    أضف إلى المفضلة
  3. 3
    Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade

    المؤلفون: Giuseppa Romeo, Rita Agostino, Daniele Caracciolo, Natale Imbesi, Pierfrancesco Tassone, Amalia Luce, Luigi Pirtoli, Alois Nečas, Pierpaolo Correale, Rocco Giannicola, Teresa Del Giudice, Nicoletta Staropoli, Evzen Amler, Pierosandro Tagliaferri, Vito Barbieri, Alessandra Strangio, Pierpaolo Pastina, Rita Emilena Saladino, M. Altomonte, Valerio Nardone, Diana Giannarelli, Paolo Tini, Valentina Arcati, Antonio Giordano, Antonia Consuelo Falzea, Michele Caraglia

    المساهمون: Correale, P., Saladino, R. E., Giannarelli, D., Giannicola, R., Agostino, R., Staropoli, N., Strangio, A., Del Giudice, T., Nardone, V., Altomonte, M., Pastina, P., Tini, P., Falzea, A. C., Imbesi, N., Arcati, V., Romeo, G., Caracciolo, D., Luce, A., Caraglia, M., Giordano, A., Pirtoli, L., Necas, A., Amler, E., Barbieri, V., Tassone, P., Tagliaferri, P.

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
    Journal for Immunotherapy of Cancer

    مصطلحات موضوعية: Male, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Immunology, Human leukocyte antigen, Cancer immunotherapy, HLA Antigens, Carcinoma, Non-Small-Cell Lung, Immunotherapy Biomarkers, medicine, Humans, Immunology and Allergy, Cytotoxic T cell, Lung cancer, Immune Checkpoint Inhibitors, Alleles, Germ-Line Mutation, RC254-282, Aged, Retrospective Studies, Pharmacology, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Survival Analysis, lung neoplasm, Immune checkpoint, HLA-A, antigen presentation, Treatment Outcome, Oncology, tumor biomarkers, B7-H1 antigen, Cancer research, Molecular Medicine, Female, Nivolumab, business, B7-H1 Antigen

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1905deaf39a4611f9d4981936aae8b4Test
    https://doi.org/10.1136/jitc-2020-000733Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث